Abstract
Unplanned excisions of soft tissue sarcomas occur with alarming frequency and result in high rates of residual disease, potentially affecting patient prognosis. To determine if unplanned excisions and residual disease status at tumor bed excision increased local recurrence rates and predicted disease-specific patient survival, we retrospectively reviewed 203 consecutive patients with high-grade soft tissue sarcomas treated operatively and followed for at least 2 years (mean, 4.8 years) or until patient death. Among the 64 patients (32%) who had undergone previous unplanned excisions, six had gross residual disease and 40 of the remaining 58 (69%) had microscopic residual disease in the tumor bed. We observed subsequent local recurrence in nine of the 139 patients (6%) after planned excision compared with 22 patients (34%) after unplanned excision. More patients with unplanned excisions who underwent limb salvage procedures required flap coverage and/or skin grafting with their definitive resection (30% versus 5%). In the unplanned excision cohort, residual disease status at tumor bed excision predicted increased rates of local recurrence and decreased disease-specific survival. Unplanned excisions of high-grade soft tissue sarcomas resulted in increased rates of local recurrence but not disease-specific survival. Residual disease at reexcision predicted the likelihood of local recurrence.
Level of Evidence: Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 1991;214:328–336.
Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A. The effect of unplanned excision of a soft tissue sarcoma on prognosis. J Bone Joint Surg Br. 2008;90:203–208.
Clasby R, Tilling K, Smith MA, Fletcher CD. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg. 1997;84:1692–1696.
Collin C, Godbold J, Hajdu S, Brennan MF. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol. 1987;5:601–612.
Collin C, Hajdu SI, Godbold J, Friedrich C, Brennan MF. Localized operable soft tissue sarcoma of the upper extremity: presentation, management, and factors affecting local recurrence in 108 patients. Ann Surg. 1987;205:331–339.
Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34:187–220.
Davis AM, Kandel RA, Wunder JS, Unger R, Meer J, O’Sullivan B, Catton CN, Bell RS. The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol. 1987;66:81–87.
Delaney TF, Kepka L, Goldberg SI, Hornicek FJ, Gebhardt MC, Yoon SS, Springfield DS, Raskin KA, Harmon DC, Kirsch DG, Mankin HI, Rosenberg AE, Nielsen GP, Suit HD. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2003;56:21–27.
Eilber FR, Morton DL, Eckardt J, Grant T, Weisenburger T. Limb salvage for skeletal and soft tissue sarcomas: multidisciplinary preoperative therapy. Cancer. 1984;53:2579–2584.
Enneking WF, Spanier SS, Malawer MM. The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer. 1981;47:1005–1022.
Fiore M, Casali PG, Miceli R, Mariani L, Bertulli R, Lozza L, Collini P, Olmi P, Mussi C, Gronchi A. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006;13:110–117.
Gerner RE, Moore GE, Pickren JW. Soft tissue sarcomas. Ann Surg. 1975;181:803–808.
Gerrand CH, Bell RS, Wunder JS, Kandel RA, O’Sullivan B, Catton CN, Griffin AM, Davis AM. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer. 2003;97:485–492.
Giuliano AE, Eilber FR. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol. 1985;3:1344–1348.
Goodlad JR, Fletcher CD, Smith MA. Surgical resection of primary soft-tissue sarcoma: incidence of residual tumour in 95 patients needing re-excision after local resection. J Bone Joint Surg Br. 1996;78:658–661.
Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
Gronchi A, Miceli R, Fiore M, Collini P, Lozza L, Grosso F, Mariani L, Casali PG. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann Surg Oncol. 2007;14:1583–1590.
Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center: a comparison of quality of surgery in 375 patients. Acta Orthop Scand. 1994;65:47–50.
Henshaw RM, Priebat DA, Perry DJ, Shmookler BM, Malawer MM. Survival after induction chemotherapy and surgical resection of high-grade soft tissue sarcoma: is radiation necessary? Ann Surg Oncol. 2001;8:484–495.
Hoeber I, Spillane AJ, Fisher C, Thomas JM. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann Surg Oncol. 2001;8:80–87.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.
Karakousis CP, Proimakis C, Walsh DL. Primary soft tissue sarcoma of the extremities in adults. Br J Surg. 1995;82:1208–1212.
Kepka L, Suit HD, Goldberg SI, Rosenberg AE, Gebhardt MC, Hornicek FJ, Delaney TF. Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas. J Surg Oncol. 2005;92:39–45.
Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF. Effect of reresection in extremity soft tissue sarcoma. Ann Surg. 2000;231:655–663.
Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997;15:646–652.
Lin PP, Guzel VB, Pisters PW, Zagars GK, Weber KL, Feig BW, Pollock RE, Yasko AW. Surgical management of soft tissue sarcomas of the hand and foot. Cancer. 2002;95:852–861.
Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982;64:1121–1127.
Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. For the members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996;78:656–663.
Manoso MW, Frassica DA, Deune EG, Frassica FJ. Outcomes of re-excision after unplanned excision of soft-tissue sarcomas. J Surg Oncol. 2005;91:153–158.
Manoso MW, Pratt J, Healey JH, Boland PJ, Athanasian EA. Infiltrative MRI pattern and incomplete initial surgery compromise local control of myxofibrosarcoma. Clin Orthop Relat Res. 2006;450:89–94.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemo Reports. 1966;50:163–170.
Noria S, Davis AM, Kandel R, Levesque J, O’Sullivan B, Wunder J, Bell R. Residual disease following unplanned excision of a soft tissue sarcoma of an extremity. J Bone Joint Surg Am. 1996;78:650–656.
Peabody TD, Monson D, Montag A, Schell MJ, Finn H, Simon MA. A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. J Bone Joint Surg Am. 1994;76:1167–1173.
Pisters PWT, Harrison LB, Leung DHY, Woodruff JM, Casper ES, Brennan MF. Long term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859–868.
Potter DA, Kinsella T, Glatstein E, Wesley R, White DE, Seipp CA, Chang AE, Lack EE, Costa J, Rosenberg SA. High-grade soft tissue sarcomas of the extremities. Cancer. 1986;58:190–205.
Rosenberg S, Tepper J, Galstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R. The treatment of soft tissue sarcoma of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196:305–315.
Rougraff BT, Davis K, Cudahy T. The impact of previous surgical manipulation of subcutaneous sarcoma on oncologic outcome. Clin Orthop Relat Res. 2005;438:85–91.
Rydholm A, Gustafson P, Rööser B, Willén H, Akerman M, Herrlin K, Alvegård T. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol. 1991;9:1757–1765.
Rydholm A, Gustafson P, Rööser B, Willén H, Berg NO. Subcutaneous sarcoma: a population-based study of 129 patients. J Bone Joint Surg Br. 1991;73:662–667.
Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975;182:597–602.
Sterne JA, Davey Smith G. Sifting the evidence: what’s wrong with significance tests? BMJ. 2001;322:226–231.
Suit HD, Proppe KH, Mankin HJ, Wood WC. Preoperative radiation therapy for sarcoma of soft tissue. Cancer. 1981;47:2269–2274.
Ward WG, Rougraff B, Quinn R, Damron T, O’Connor MI, Turcotte RE, Cline M. Tumors masquerading as hematomas. Clin Orthop Relat Res. 2007;465:232–240.
Wilson AN, Davis A, Bell RS, O’Sullivan B, Catton C, Madadi F, Kandel R, Fornasier VL. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer. 1994;30A:746–751.
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.
Zeytoonjian T, Mankin HJ, Gebhardt MC, Hornicek FJ. Distal lower extremity sarcomas: frequency of occurrence and patient survival. Foot Ankle Int. 2004;25:325–330.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Each author certifies that this or her institution has approved the reporting of these cases, that all investigations were conducted in conformity with ethical principles of research, and that a waiver of informed consent for participating in this study was obtained.
About this article
Cite this article
Potter, B.K., Adams, S.C., Pitcher, J.D. et al. Local Recurrence of Disease after Unplanned Excisions of High-grade Soft Tissue Sarcomas. Clin Orthop Relat Res 466, 3093–3100 (2008). https://doi.org/10.1007/s11999-008-0529-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-008-0529-4